首页 产品目录 分子砌块 按反应类型 五元杂环胺化 6-(环丙烷甲酰胺基)-4-((2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯基)氨基)-N-(甲基-d3)哒嗪-3-甲酰胺

6-(环丙烷甲酰胺基)-4-((2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯基)氨基)-N-(甲基-d3)哒嗪-3-甲酰胺

6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 99% 询价
- +
5mg 99% 询价
- +
10mg 99% 询价
- +
250mg 99% 询价
- +
1g 99% 询价
- +
5g 99% 询价
- +
10g 99% 询价
- +
25g 99% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1609392-27-9

中文名称

6-(环丙烷甲酰胺基)-4-((2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯基)氨基)-N-(甲基-d3)哒嗪-3-甲酰胺

英文名称

6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide

别名

Deucravacitinib | NSC825520 | compound 11 [PMID: 31318208} | EN300-22276121 | Deucravacitinib [USAN] | (BMS-986165) | SCHEMBL20520348 | Sotyktu | AT18623 | DEUCRAVACITINIB [JAN] | 6-[(Cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3

标准英文名

6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide

MDL No.

MFCD31715455

分子式

C20H22N8O3

分子量

425.47

精确分子量

425.20

SMILES

[2H]C([2H])([2H])NC(=O)C1=NN=C(NC(=O)C2CC2)C=C1NC1=CC=CC(C2=NN(C)C=N2)=C1OC

标准SMILES

[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC1=CC=CC(C2=NN(C)C=N2)=C1OC)NC(=O)C1CC1

用途

Deucravacitinib (BMS-986165) is a first-in-class, oral, selective tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of moderate-to-severe plaque psoriasis; it represents a promising therapeutic option for effective management of psoriasis due to its unique mechanism of action.

InChIKey

BZZKEPGENYLQSC-FIBGUPNXSA-N

安全信息

SureRoute逆合成路线

1.  1609392-27-9 逆合成路线 1

—
—
ACFADS597
1609394-10-6
现货
ACOLNF295
1609392-27-9
来源: SureRoute

2.  1609392-27-9 逆合成路线 2

—
—
—
—
ACOLNF295
1609392-27-9
来源: SureRoute

3.  1609392-27-9 逆合成路线 3

—
—
—
—
ACOLNF295
1609392-27-9
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手